Human Ciliary Muscle Cell Responses to FP-Class Prostaglandin Analogs: Phosphoinositide Hydrolysis, Intracellular Ca2+ Mobilization and MAP Kinase Activation-Reference-Cited by-同舟云学术

Human Ciliary Muscle Cell Responses to FP-Class Prostaglandin Analogs: Phosphoinositide Hydrolysis, Intracellular Ca2+ Mobilization and MAP Kinase Activation

Published:2003-10 Issue:5 Volume:19 Page:437-455
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Sharif Naj A.¹,Crider Julie Y.¹,Husain Shahid²,Kaddour-Djebbar Ismail²,Ansari Habib R.²,Abdel-Latif Ata A.²

Affiliation:

1. Molecular Pharmacology Unit, Alcon Research, Ltd., Fort Worth, TX

2. Department of Biochemistry and Molecular Biology, School of Medicine, Medical College of Georgia, Augusta, GA

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/108076803322473006

Reference56 articles.

1. Open-Angle Glaucoma

2. [3H]AL-5848 ([3H]9β-(+)-Fluprostenol). Carboxylic Acid of Travoprost (AL-6221), a Novel FP Prostaglandin o study the Pharmacology and Autoradiographic Localization of the FP Receptor

3. Preclinical Efficacy of Travoprost, a Potent and Selective FP Prostaglandin Receptor Agonist

4. Identification and Characterization of the Ocular Hypotensive Efficacy of Travoprost, a Potent and Selective FP Prostaglandin Receptor Agonist, and AL-6598, a DP Prostaglandin Receptor Agonist

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial;Translational Vision Science & Technology;2024-01-29

2. FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma;Experimental Eye Research;2023-04

3. Neuroaxonal and cellular damage/protection by prostanoid receptor ligands, fatty acid derivatives and associated enzyme inhibitors;Neural Regeneration Research;2023

4. Screening strategies for drug discovery-focus on ocular hypertension;Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics;2022

5. Various forms of glaucoma and their treatments;Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics;2022